These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11707405)

  • 1. ShcA tyrosine phosphorylation sites can replace ShcA binding in signalling by middle T-antigen.
    Nicholson PR; Empereur S; Glover HR; Dilworth SM
    EMBO J; 2001 Nov; 20(22):6337-46. PubMed ID: 11707405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. Identification of a new Grb2.Sos1 binding site.
    Thomas D; Bradshaw RA
    J Biol Chem; 1997 Aug; 272(35):22293-9. PubMed ID: 9268379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases.
    Lock LS; Royal I; Naujokas MA; Park M
    J Biol Chem; 2000 Oct; 275(40):31536-45. PubMed ID: 10913131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Grb2-associated docking protein in EGF- and insulin-receptor signalling.
    Holgado-Madruga M; Emlet DR; Moscatello DK; Godwin AK; Wong AJ
    Nature; 1996 Feb; 379(6565):560-4. PubMed ID: 8596638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
    Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
    J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.
    Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N
    Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells.
    Audero E; Cascone I; Maniero F; Napione L; Arese M; Lanfrancone L; Bussolino F
    J Biol Chem; 2004 Mar; 279(13):13224-33. PubMed ID: 14665640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
    Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
    Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.
    Rozakis-Adcock M; Fernley R; Wade J; Pawson T; Bowtell D
    Nature; 1993 May; 363(6424):83-5. PubMed ID: 8479540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
    Charest A; Wagner J; Kwan M; Tremblay ML
    Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
    J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
    Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
    Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of ShcA signaling halts cell proliferation--characterization of ShcC residues that influence signaling pathways using yeast.
    Heinrich JN; Kwak SP; Howland DS; Chen J; Sturner S; Sullivan K; Lipinski K; Cheng KY; She Y; Lo F; Ghavami A
    Cell Signal; 2006 Jun; 18(6):795-806. PubMed ID: 16126371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering NGF receptors to bind Grb2 directly uncovers differences in signaling ability between Grb2- and ShcA-binding sites.
    Oku S; van der Meulen T; Copp J; Glenn G; van der Geer P
    FEBS Lett; 2012 Oct; 586(20):3658-64. PubMed ID: 22968039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.